Octreotide was less potent than pasireotide at inhibiting ACTH secretion in corticotropinomas [28], whereas in primary NFPT cells neither drug affected cell viability [17], or pasireotide was less effective than octreotide at reducing it [17]. Here, POMC is linked to ACTH-producing pituitary gland adenoma.